Despite growth in enrollment, fewer than 5% of US dogs and cats are insured, while rising veterinary costs are increasingly affecting treatment decisions and access to recommended care.
|Articles|September 19, 2014
FDA warns makers of tear stain removers to pull products from market
The U.S. Food and Drug Administration (FDA) has issued a warning to the makers of certain over-the-counter products designed to remove tear stains in dogs and cats.
Advertisement
The U.S. Food and Drug Administration (FDA) has issued a warning to the makers of certain over-the-counter products designed to remove tear stains in dogs and cats. The FDA wants distribution to stop until products can be reviewed for safety and effectiveness. The agency submitted letters to the manufacturers of Angels' Eyes, Angels' Glow, Pets' Spark, Glow Groom and Health Glow, as these products contain the antibiotic tylosin tartate, which is not approved for use in dogs and cats. The antibiotic has also not been approved for treatment of conditions such as epiphora, commonly associated with tear stains.
Advertisement
According to the FDA, these products may be subject to further enforcement action, including seizure or injunction against the companies that manufacture or distribute them, if they continue to be marketed.
To read more about the FDA's warning to manufacturers, go to
Advertisement
Related to this article
A survey of more than 26,000 adults in 14 countries found that many people are open to adopting a pet but hold back because of what they don't know about the animal's past.
A pain management protocol is only as good as the conversation behind it.
Mindy Cannon, MBA, explains what 4CYTE is, how it is dosed, and where veterinary practices can find it, in this episode of The Vet Blast Podcast presented by dvm360
Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), explains Toxoplasma gondii facts, including why most indoor cats rarely shed, as well as pregnancy-safe litter tips for cat health.
The latest updates relating to animal care establishments and platforms.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
The first survey of parasite control on bison ranches shows most herds are dewormed on a schedule, with little testing to see whether they need it. Researchers say the habit could make resistance harder to manage.
Advertisement
Advertisement
Trending on dvm360
1
A catastrophic miscarriage of justice: The truth about Toxoplasma gondii risk from household cats
2
Natural Bridge Wildlife Ranch welcomes third southern white rhino calf in 3 years
3
Clinic center: Boehringer Ingelheim opens new US animal health headquarters in Georgia, Purina unveils $550 million pet food manufacturing facility in Ohio, and more
4
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
5